NCT00016094View on ClinicalTrials.gov

S0108 Bevacizumab in Treating Patients With Non-Hodgkin's Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 30, 2001

Primary Completion Date

August 31, 2005

Study Completion Date

September 30, 2008

Conditions
Anaplastic Large Cell LymphomaRecurrent Adult Burkitt LymphomaRecurrent Adult Diffuse Large Cell LymphomaRecurrent Mantle Cell Lymphoma
Interventions
BIOLOGICAL

bevacizumab

Given IV

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

78245

Southwest Oncology Group, San Antonio

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00016094 - S0108 Bevacizumab in Treating Patients With Non-Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter